Kelly MacDonald, Chief Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 1,153 shares at $10.35 ($12K) on 2020-05-11, disclosed to the SEC on 2020-05-13.
Scheduled sale ($12k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.35 | 558 | $6K | 48.4% |
| 2 | $10.35 | 595 | $6K | 51.6% |
| Total | $10.35 avg | 1,153 | $12K | 100% |
| Filing → |
| IRWD | SELL | 2020-11-10 | $31K | — | Filing → |
| IRWD | SELL | 2020-10-13 | $238K | — | Filing → |
| IRWD | SELL | 2020-08-19 | $6K | — | Filing → |